Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel pyridine-thiazolidinone-triazole hybrid glycosides targeting EGFR and CDK-2: Design, synthesis, anticancer evaluation, and molecular docking simulation
Asmaa F. Kassem, Mohamed A. Omar, Eman S. Nossier, et al.
Journal of Molecular Structure (2023) Vol. 1294, pp. 136358-136358
Closed Access | Times Cited: 17

Showing 17 citing articles:

Thiazole moiety: A promising scaffold for anticancer drug discovery
Asmaa F. Kassem, Raed H. Althomali, Manal M. Anwar, et al.
Journal of Molecular Structure (2024) Vol. 1303, pp. 137510-137510
Closed Access | Times Cited: 11
Targeting cyclin-dependent kinase 2 CDK2: Insights from molecular docking and dynamics simulation – A systematic computational approach to discover novel cancer therapeutics
Bharath Kumar Chagaleti, Shantha Kumar B., Anjana G.V., et al.
Computational Biology and Chemistry (2024) Vol. 112, pp. 108134-108134
Closed Access | Times Cited: 8
Novel Nano-sized N-Thiazolylpyridylamines Targeting CDK2: Design, Divergent Synthesis, Conformational Studies, and Multifaceted In Silico Analysis
Samir Bondock, Nada Alabbad, Aisha Hossan, et al.
Chemico-Biological Interactions (2025), pp. 111366-111366
Closed Access
Tandem Synthesis and Computational Insights into Triazole and Pyrazole-Based Pyridine Derivatives Targeting EGFR-TK in Cancer Therapy
Samir Bondock, Nada Alabbad, Rehab H. Abd El‐Aleam, et al.
Polycyclic aromatic compounds (2025), pp. 1-24
Closed Access
New Benzimidazole-Triazole Derivatives as Topoisomerase I Inhibitors: Design, Synthesis, Anticancer Screening, and Molecular Modeling Studies
Ulviye Acar Çevik, Betül Kaya, İsmail Çeli̇k, et al.
ACS Omega (2024)
Open Access | Times Cited: 5
Click synthesis, anticancer and molecular docking evaluation of some hexahydro-6H-indolo[2,3-b]quinoxalines incorporated triazole moiety
Tamer El Malah, Randa El-Sayed Abd El-Mageid, Ahmed H. Shamroukh, et al.
Journal of Molecular Structure (2024) Vol. 1303, pp. 137573-137573
Closed Access | Times Cited: 3
Designing Potent Anti-Cancer Agents: Synthesis and Molecular Docking Studies of Thieno[2,3-d][1,2,4]triazolo[1,5-a]pyrimidine Derivatives
Eman S. M. Elsenbawy, Zafer Saad Alshehri, Nouf A. Babteen, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 1067-1067
Open Access | Times Cited: 2
New sulfonamide-based glycosides incorporated 1,2,3-triazole as cytotoxic agents through VEGFR-2 and carbonic anhydrase inhibitory activity
Hebat‐Allah S. Abbas, Eman S. Nossier, May A. El‐Manawaty, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
An updated review on 1,2,3-/1,2,4-triazoles: synthesis and diverse range of biological potential
Anirudh Pratap Singh Raman, M. Aslam, Amardeep Awasthi, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 2
Pyridine-Based Glycosides Bearing 1,2,4-Triazole and Their 1,3,4-oxadiazole analogues as Potential EGFR and CDK-2 Inhibitors: Design, Synthesis, Antiproliferative Activity and In Silico Studies
Asmaa F. Kassem, Ahmed Younis, Eman S. Nossier, et al.
Journal of Molecular Structure (2024) Vol. 1313, pp. 138741-138741
Closed Access | Times Cited: 1
Design, synthesis and in vitro anti-proliferative evaluation of new pyridine-2,3-dihydrothiazole/thiazolidin-4-one hybrids as dual CDK2/GSK3β kinase inhibitors
Asmaa F. Kassem, Ashraf A. Sediek, Mervat M. Omran, et al.
RSC Advances (2024) Vol. 14, Iss. 43, pp. 31607-31623
Open Access | Times Cited: 1
Comprehensive analysis and outcomes of hybridization of physiologically active heterocycles targeting epidermal growth factor receptor (EGFR)
Mandeep Kaur, Hafiz Muzzammel Rehman, Yurong Wu, et al.
Computers in Biology and Medicine (2024) Vol. 184, pp. 109347-109347
Closed Access | Times Cited: 1
Design of Sulfonamide-Based Glycosides Incorporated with 1,2,3-Triazole Scaffold as Potential VEGFR-2 and Carbonic Anhydrase Inhibitors: Synthesis, Cytotoxic Activity and In Silico Studies
Mohamed N. El-Bayaa, Eman S. Nossier, May A. El‐Manawaty, et al.
Research Square (Research Square) (2024)
Open Access
Synthesis, characterization and in silico studies of coumarin-chalcone derivatives and their cytotoxicity activity against breast cancer cells
Muhammad Rahama, Melati Khairuddean, Noor Zafirah Ismail, et al.
Journal of Molecular Structure (2024), pp. 140341-140341
Closed Access
Novel quinazolin-4-one based derivatives bearing 1,2,3-triazole and glycoside moieties as potential cytotoxic agents through dual EGFR and VEGFR-2 inhibitory activity
Adel A.‐H. Abdel‐Rahman, Mohamed N. El-Bayaa, Asmaa Sobhy, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Novel Thiazolinone Derivatives: Synthesis, Biological Evaluation, and In Silico Studies
W. O. Alsulami, Zahra M. Al-Amshany, Nada Y. Tashkandi, et al.
Russian Journal of Organic Chemistry (2024) Vol. 60, Iss. 9, pp. 1705-1719
Closed Access
New pyrano-pyridine conjugates as potential anticancer agents: design, synthesis and computational studies
Aladdin M. Srour, Eman S. Nossier, Najla Altwaijry, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 24, pp. 2567-2582
Closed Access
Page 1

Scroll to top